Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8871192 IL-1F8 polypeptides

Patent 8871192 was granted and assigned to Amgen on October, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Amgen

Current Assignee

Amgen

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

88711920

Patent Inventor Names

Randal R. Ketchem0

Blair R. Renshaw0

Christopher Gabel0

Jennifer E. Towne0

John E. Sims0

Date of Patent

October 28, 2014

Patent Application Number

139152630

Date Filed

June 11, 2013

Patent Citations Received

‌

US Patent 11926665 Methods of treating cancer with anti-TIM-3 antibodies

‌

US Patent 11753472 Antibodies directed against T cell immunoglobulin and mucin protein 3 (TIM-3)

Patent Primary Examiner

‌

Ruixiang Li

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8871192 IL-1F8 polypeptides

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API